Management of stage I and II cervical cancer: a review

In the modern era, cervical cancer treatment has become more multidisciplinary in nature. Accurate and precise staging based on clinical and radiographic findings, as well as identification of pathologic and molecular risk factors, may alter treatment recommendations. Additionally, the body of evide...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of gynecological cancer Vol. 32; no. 3; pp. 216 - 224
Main Authors Chou, Brian, Prasad Venkatesulu, Bhanu, Coleman, Robert L, Harkenrider, Matthew, Small Jr, William
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd 01.03.2022
BMJ Publishing Group LTD
Subjects
Age
Biopsy
Cancer therapies
Cell cycle
Cervical cancer
Cervix
Cervix Uteri - pathology
Chemoradiotherapy
Developing countries
Female
Fertility
Gynecology
Human papillomavirus
Humans
LDCs
Lymphatic system
Medical screening
Microscopy
Neoplasm Staging
Obstetrics
Pregnancy
Review
Surgeons
Uterine Cervical Neoplasms - pathology
Uterus
Vaccines
Vagina
cervical cancer
Online AccessGet full text

Cover

More Information
Summary:In the modern era, cervical cancer treatment has become more multidisciplinary in nature. Accurate and precise staging based on clinical and radiographic findings, as well as identification of pathologic and molecular risk factors, may alter treatment recommendations. Additionally, the body of evidence guiding optimal treatment recommendations continues to grow. Multiple specialists including gynecologic oncologists, radiation oncologists, medical oncologists, radiologists, pathologists, and other ancillary staff, often with subspecialty experience in gynecology or cancer care, now staff multidisciplinary gynecologic oncology teams. This review highlights the basis of multidisciplinary treatment of early-stage cervical cancer, with a focus on surgical interventions, the role of adjuvant therapy, and indications for definitive chemoradiation. We specifically focus on the treatment of cervical cancer from stage IA1 (microinvasive disease) to stage IIB (parametrial involvement without involvement of pelvic sidewall). The staging manuals referenced in this review include the International Federation of Gynecology and Obstetrics (FIGO) 2018 staging as well as the updated American Joint Committee on Cancer (AJCC) 9th edition (2021).
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1048-891X
1525-1438
DOI:10.1136/ijgc-2021-002527